b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">29900640</PMID>\n        <DateCompleted>\n            <Year>2018</Year>\n            <Month>09</Month>\n            <Day>04</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>04</Month>\n            <Day>15</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1349-7006</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>109</Volume>\n                    <Issue>8</Issue>\n                    <PubDate>\n                        <Year>2018</Year>\n                        <Month>Aug</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Cancer science</Title>\n                <ISOAbbreviation>Cancer Sci.</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Integrin \xce\xb21 is an essential factor in vasculogenic mimicry of human cancer cells.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>2490-2496</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1111/cas.13693</ELocationID>\n            <Abstract>\n                <AbstractText>Vasculogenic mimicry (VM) formation by cancer cells is known to play a crucial role in tumor progression, but its detailed mechanism is unclear. In the present study, we focused on integrin \xce\xb21 (ITGB1) and assessed the role of ITGB1 in VM formation. We used in vitro methods to seed cancer cells on Matrigel to evaluate the capability of VM formation. We carried out ITGB1 gene deletion using the CRISPR/Cas9 system, and these ITGB1-knockout cells did not show a VM-like network formation. Further, reintroduction of ITGB1 rescued VM-like network formation in ITGB1-knockout cells. In conclusion, ITGB1 is a critical factor in VM of human cancer cells, and inhibition of ITGB1 may be a novel therapeutic approach for malignant cancer.</AbstractText>\n                <CopyrightInformation>\xc2\xa9 2018 The Authors. Cancer Science published by John Wiley &amp; Sons Australia, Ltd on behalf of Japanese Cancer Association.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Kawahara</LastName>\n                    <ForeName>Ryota</ForeName>\n                    <Initials>R</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Applied Chemistry, Faculty of Science and Technology, Keio University, Yokohama, Japan.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Niwa</LastName>\n                    <ForeName>Yuki</ForeName>\n                    <Initials>Y</Initials>\n                    <Identifier Source="ORCID">http://orcid.org/0000-0001-8991-0155</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Applied Chemistry, Faculty of Science and Technology, Keio University, Yokohama, Japan.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Simizu</LastName>\n                    <ForeName>Siro</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Applied Chemistry, Faculty of Science and Technology, Keio University, Yokohama, Japan.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2018</Year>\n                <Month>07</Month>\n                <Day>09</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>England</Country>\n            <MedlineTA>Cancer Sci</MedlineTA>\n            <NlmUniqueID>101168776</NlmUniqueID>\n            <ISSNLinking>1347-9032</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D019012">Integrin beta1</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D064113" MajorTopicYN="N">CRISPR-Cas Systems</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D017353" MajorTopicYN="N">Gene Deletion</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D019012" MajorTopicYN="N">Integrin beta1</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D009389" MajorTopicYN="N">Neovascularization, Pathologic</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>\n                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword>\n            <Keyword MajorTopicYN="N">focal adhesion kinase</Keyword>\n            <Keyword MajorTopicYN="N">integrin \xce\xb21</Keyword>\n            <Keyword MajorTopicYN="N">metastasis</Keyword>\n            <Keyword MajorTopicYN="N">vasculogenic mimicry</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2018</Year>\n                <Month>03</Month>\n                <Day>19</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2018</Year>\n                <Month>06</Month>\n                <Day>01</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2018</Year>\n                <Month>06</Month>\n                <Day>08</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2018</Year>\n                <Month>6</Month>\n                <Day>15</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2018</Year>\n                <Month>9</Month>\n                <Day>5</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2018</Year>\n                <Month>6</Month>\n                <Day>15</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">29900640</ArticleId>\n            <ArticleId IdType="doi">10.1111/cas.13693</ArticleId>\n            <ArticleId IdType="pmc">PMC6113431</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>Angiogenesis. 2016 Apr;19(2):191-200</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26899730</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>FEBS Lett. 2015 Mar 12;589(6):738-43</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25680527</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Oncol. 2013 Jun;42(6):2103-15</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23588386</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Biomed Res Int. 2014;2014:803914</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24864260</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cell Growth Differ. 1994 Aug;5(8):891-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">7986754</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Cancer. 2015 Mar 15;136(6):E545-58</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25284767</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Protoc. 2013 Nov;8(11):2281-2308</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24157548</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Res. 2002 Jan 15;62(2):560-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11809710</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncotarget. 2016 Apr 26;7(17):24050-62</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26992227</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Exp Cell Res. 1998 Jan 10;238(1):197-203</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">9457072</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Exp Clin Cancer Res. 2016 Nov 11;35(1):175</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27836001</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Cancer Ther. 2015 Jul;14(7):1582-90</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25934709</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Exp Cell Res. 2001 Feb 1;263(1):65-76</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11161706</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Res. 1995 Jul 1;55(13):2752-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">7796399</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Biol Cell. 2015 Oct 15;26(20):3658-70</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26310447</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>FEBS Lett. 2012 May 21;586(10):1504-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22673517</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Am J Pathol. 1999 Sep;155(3):739-52</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">10487832</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Sci Rep. 2017 Apr 20;7:46659</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28425453</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cell. 2002 Sep 20;110(6):673-87</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12297042</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>FEBS Lett. 2016 Apr;590(8):1152-62</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27001232</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Cell Sci. 2010 Apr 1;123(Pt 7):1007-13</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20332118</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Rev Mol Cell Biol. 2010 Nov;11(11):802-14</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20966971</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Sci Rep. 2016 Jan 05;6:18430</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26728650</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Huazhong Univ Sci Technolog Med Sci. 2012 Jun;32(3):346-352</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22684556</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Sci Rep. 2017 Oct 25;7(1):13996</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29070803</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Am Chem Soc. 2006 Mar 22;128(11):3554-63</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16536528</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Commun. 2016 Nov 09;7:13322</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27827359</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Semin Oncol. 2002 Dec;29(6 Suppl 16):15-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12516034</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>PLoS One. 2015 Apr 01;10(4):e0121667</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25830530</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Lett. 2017 Jan 28;385:28-38</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27832972</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Commun. 2017 Nov 21;8(1):1651</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29162797</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Gynecol Oncol. 2014 Jun;133(3):575-83</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24589413</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Am J Cancer Res. 2017 Mar 01;7(3):531-542</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28401009</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Rev Mol Cell Biol. 2013 Jul;14(7):430-42</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23719537</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>PLoS One. 2014 May 08;9(5):e96982</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24811250</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Microcirculation. 2011 Jul;18(5):390-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21438962</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'